Examination of Fiscal Management and the Allocation of Care Act Resources US Department of Health and Human Services: Health REsources and Services Administration
INTRODUCTION
HIV/HCV Coinfection
HCV 101
HIV/HCV Coinfection
HCV Diagnostic Testing
Hepatitis A and Hepatitis B Vaccination
Counseling and Support
HCV Treatment
Expanding Access to Treatment
Barriers and Key Issues
Conclusion
Resources
References

HCV antibody status may be a marker for poorer access to care and competing problems with addiction that lead to delays in care and failure to implement the standard of care. . . . [I]f we are to improve the health status of patients with HIV/HCV coinfection, perhaps we should focus on these issues as well the presence of the two viruses.5

—Graham and Koziel (2003)

HIV/HCV COINFECTION

HIV/HCV coinfection in the United States requires that HIV/AIDS service providers, health planners, and administrators acquire an understanding of how coinfection affects the health and well-being of their clients, and then build systems of care that respond to those effects.

But comprehending the consequences of HIV/HCV coinfection is difficult without first being familiar with the natural history of HCV monoinfection.
 
<< INTRODUCTION • HCV 101 >>